大肠癌筛查经济学评价研究进展

doi:10.11904/j.issn.1002-3070.2015.05.017

Abstract

Abstract: Colorectal cancer(CRC)has become one of the major cancer threatening residents′ health all around the world,and considerable resources are needed for its prevention and control.Economics evaluation could provide the basis of decision-making for improving the allocation efficiency of health resources in the field of CRC prevention and control.This paper comprehensively reviewed the papers that have been published in the field of colorectal cancer screening,from the points of view of published time,regional economic evaluation research,evaluation method,the research angle,input and output measurement,model,recommend strategy.

Key words: Colorectal cancer , Screening, Health economic evaluation

CLC Number:

R191

HUANG Weidong, YU Hongjuan, ZHENG Erwei, HE Changzhi, ZHAO Xiaowen, LIU Guoxiang. Progress on health economic evaluation of colorectal cancer screening[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(5): 462-466.

References

1 Shimbo T,Glick HA,Eisenberg JM.Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan[J].Int J Technol Assess Health Care,1994,10(3):359-375.
2 Whyte S,Chilcott J,Halloran S,Reappraisal of the options for colorectal cancer screening in England[J].Colorectal Dis,2012,14(9):547-561.
3 Wang ZH,Gao QY,Fang JY.Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese:a cost-effectiveness analysis[J].Asian Pac J Cancer Prev,2012,13(5):1761-1766.
4 Sharp L,Tilson L,Whyte S,et al.Cost-effectiveness of population-based screening for colorectal cancer:a comparison of guaiac-based faecal occult blood testing,faecal immunochemical testing and flexible sigmoidoscopy[J].British Journal of Cancer,2012,106(5):805-816.
5 Lucidarme O,Cadi M,Berger G,et al.Cost-effectiveness modeling of colorectal cancer:computed tomography colonography vs colonoscopy or fecal occult blood tests[J].Eur J Radiol,2012,81(7):1413-1419.
6 Dan YY,Chuah BY,Koh DC,et al.Screening based on risk for colorectal cancer is the most cost-effective approach[J].Clin Gastroenterol Hepatol,2012,10(3):266-271.
7 Barouni M,Larizadeh MH,Sabermahani A,et al.Markov′s modeling for screening strategies for colorectal cancer[J].Asian Pacific Journal of Cancer Prevention,2012,13(10):5125-5129.
8 Vijan S,Hwang I,Inadomi J,et al.The cost-effectiveness of CT colonography in screening for colorectal neoplasia[J].American Journal of Gastroenterology,2007,102(2):380-390.
9 Paul T,James C,Simon E,et al.Option appraisal of population-based colorectal cancer screening programmes in England[J].Gut,2007,56(5):677-684.
10 Sieg A,Brenner H.Cost-saving analysis of screening colonoscopy in germany[J].Zeitschrift Für Gastroenterologie,2007,45(9):945-951.
11 Pickhardt PJ,Cesare H,Andrea L,et al.Cost-effectiveness of colorectal cancer screening with computed tomography colonography:the impact of not reporting diminutive lesions[J].Cancer,2007,109(11):2213-2221.
12 Hassan C,Zullo A,Laghi A,et al.Colon cancer prevention in Italy:Cost-effectiveness analysis with CT colonography and endoscopy[J].Dig Liver Dis,2007,39(3):242-250.
13 Chen LS,Liao CS,Chang SH,et al.Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening(KCIS 16)[J].J Med Screen,2007,14(4):191-199.
14 Lieberman D.Cost-effectiveness of screening colorectal cancer in the general population[J].Gastrointestinal Endoscopy,2001,54(4):537-538.
15 Khandker,RK,Dulski JD,Kilpatrick JB,et al.A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults[J].Int J Technol Assess Health Care,2000,16(3):799-810.
16 Loeve F,Brown ML,Boer R,et al.Endoscopic colorectal cancer screening:A cost-saving analysis[J].Journal of the National Cancer Institute,2000,92(7):557-563.
17 Ness RM,Holmes AM,Klein R,et al.Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages[J].American Journal of Gastroenterology,2000,95(7):1800-1811.
18 Sonnenberg A,Delcò F,Inadomi JM.Cost-effectiveness of colonoscopy in screening for colorectal cancer[J].Annals of Internal Medicine,2000,133(8):573-584.
19 Sonnenberg A,Delcò F,Bauerfeind P.Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?[J].American Journal of Gastroenterology,1999,94(8):2268-2274.
20 Vijan S,Hwang EW,Hofer TP,et al.Which colon cancer screening test? A comparison of costs,effectiveness,and compliance[J].American Journal of Medicine,2001,111(8):593-601.
21 Parekh M,Fendrick A,Ladabaum U.As tests evolve and costs of cancer care rise:reappraising stool-based screening for colorectal neoplasia[J].Alimentary Pharmacology & Therapeutics,2008,27(8):697-712.
22 Hassan C,Zullo A,Winn S,et al.Cost-effectiveness of capsule endoscopy in screening for colorectal cancer[J].Endoscopy,2008,40(5):414-421.
23 Ho C,Heitman S,Membe SK,et al.Computed tomographic colonography for colorectal cancer screening in an average risk population:Systematic review and economic evaluation[D].Ottawa:Canadian Agency for Drugs and Technologies in Health;2008.
24 Telford JJ,Levy AR,Sambrook JC,et al.RESEARCH.The cost-effectiveness of screening for colorectal cancer[J].Cmaj Canadian Medical Association Journal,2010,182(12):1307-1313.
25 Heitman SJ,Hilsden RJ,Au F,et al.Colorectal Cancer Screening for Average-Risk North Americans:An Economic Evaluation[J].PLoS Medicine,2010,7(11):e1000370.
26 Berchi C,Bouvier V,Réaud JM,et al.Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France[J].Health Economics,2004,13(3):227-238.
27 Lejeune C,Arveux P,Dancourt V,et al.Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer[J].Int J Technol Assess Health Care,2004,20(4):434-439.
28 Lejeune C,Dancourt V,Arveux P,et al.Cost-effectiveness of screening for colorectal cancer in france using a guaiac test versus an immunochemical test[J].Int J Technol Assess Health Care,2010,26(1):40-47.
29 Heresbach D,Chauvin P,Grolier J,et al.Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests[J].Eur J Gastroenterol Hepatol,2010,22(11):1372-1379.
30 Hassan C,Benamouzig R,Spada C,et al.Cost effectiveness and projected national impact of colorectal cancer screening in France[J].Endoscopy,2011,43(9):780-793.
31 Daniels K,McKee M.Options for screening for colorectal cancer in the Royal Air Force:a cost-effectiveness evaluation[J].Journal of the Royal Army Medical Corps,1995,141(3):142-150.
32 Whynes DK,Neilson AR,Walker AR,et al.Faecal occult blood screening for colorectal cancer:is it cost-effective?[J].Health Economics,1998,7(1):21-29.
33 Whynes DK,Nottingham FOB Screening Trial.Cost-effectiveness of screening for colorectal cancer:evidence from the Nottingham faecal occult blood trial[J].J Med Screen,2004,11(1):11-15.
34 Wilschut JA,Lieke H,Evelien D,et al.Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening[J].Gastroenterology,2011,141(5):1648-55.e1.
35 van Rossum LG,van RiJn AF,Verbeek AL,et al.Colorectal cancer screening comparing no screening,immunochemical and guaiac fecal occult blood tests:a cost-effectiveness analysis[J].Int J Cancer,2011,128(8):1908-1917.
36 Sorrentino D,Paduano R,Bernardis V,et al.Colorectal cancer screening in Italy:feasibility and cost-effectiveness in a model area[J].Eur J Gastroenterol Hepatol,1999,11(6):655-660.
37 Norum J.Prevention of colorectal cancer:A cost-effectiveness approach to a screening model employing sigmoidoscopy[J].Annals of Oncology,1998,9(6):34-35.
38 Wu GH,Wang YM,Yen AM,et al.Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries[J].BMC Cancer,2006,6(16):136-148.
39 Wong SS,Leong AP,Leong TY.Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore:a dynamic decision analytic approach[J].Stud Health Technol Inform,2004,107(1):104-110.
40 Leshno M,Halpern Z,Arber N.Cost-effectiveness of colorectal cancer screening in the average risk population[J].Health Care Management Science,2003,6(3):165-174.
41 Tsoi KKF,Ng SSM,Leung MCM,et al.Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia[J].Alimentary Pharmacology & Therapeutics,2008,28(3):353-363.
42 Salkeld G,Young G,Irwig L.Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia[J].Aust N Z J Public Health,1996,20(2):138-143.

[1]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[2]	TONG Guanghai, TIAN Yang, WU Huaxing. Application of lipidomics in colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 179-192.
[3]	LIU Hengchen, ZHANG Xinyu. Toll-like receptor signaling pathway as a potential therapeutic target for colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 188-192.
[4]	LIU Hongtao, ZHANG Tongtong, LIU Yanjun. Research progress in the pathogenesis of obesity and colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 464-467.
[5]	WANG Zhi,LIU Zhongwei,ZENG Xueyun,SUI Mingjie,LIAO Jingyi,LI Yuehuan,HUANG Weidong,LIU Guoxiang. Health-related quality of life in patients with colorectal cancer precancerous lesions on EQ-5D-5L [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 320-326.
[6]	CUI Xueyang,XING Chengzhong. The research and application of liquid biopsy in the field of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 367-370.
[7]	LI Wenqi,GENG Jingshu. Research progress of RAS,RAF mutation and MSI status in the treatment of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 371-376.
[8]	ZHANG Xialan, SHEN Xikun, HUANG Yuyu. Application of nutritional status screening in advanced cancer patients by nutrition risk screening 2002 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 229-233.
[9]	LV Qiang, CHEN Hongsheng, LI Guodong, WEI Jiufeng, LIU Ming. Effects of tumor-associated fibroblasts in the development of colorectal cancer and its research progress [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 275-279.
[10]	KONG Weijia, AN Tian, LV Bo, JIANG Guangjian. Current status:low dose spiral CT lung screening and pulmonary nodules [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 68-72.
[11]	ZHANG Shanshan, WU Huaxing. Aplication of metabolomics in the diagnosis of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 573-576.
[12]	SUN Lina, ZHAO Xiaodi, LU Yuanyuan, WANG Xin. Research progress of LncRNA and chemotherapy resistance in gastrointestinal neoplasms [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 448-453.
[13]	HAO Xiaojun,WANG Chuanzhuo,ZHAO Xiangxuan,XIN he,LIU Zhaoyu. Effects of miR-34a on proliferation,migration and invasion of colon cancer SW480 cell and its possible mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 193-198.
[14]	GU Xiuying,GU Xiaofen,ZHU Junyu,ZHOU Tianhong,ZHU Lin. Analysis of lung cancer screening results of 9265 urban residents in Urumqi from year 2014 to 2016 [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 242-245.
[15]	ZHANG Ming,ZHU Xinqiang,DING Chuang,KONG Lingyong,CHEN Yan. Application of postoperative nutritional index in prognosis evaluation of colorectal cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 131-136.

Progress on health economic evaluation of colorectal cancer screening

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments